. 2017 Mar 31;17:183. doi: 10.1186/s12906-017-1692-5

Table 3.

Summary of outcome measures and assessment schedule

Measure	Baseline	Intervention				2-week posttreatment	12-week posttreatment
Measure	Baseline	2nd	4th	6th	8th	2-week posttreatment	12-week posttreatment
BZ cessation rate^a	✓					✓	✓
BZ dose reduction, %	✓	✓	✓	✓	✓	✓	✓
BWSQ	✓	✓	✓	✓	✓	✓	✓
ISI	✓		✓			✓	✓
HADS	✓		✓			✓	✓
SDS	✓
CTRS	✓	✓			✓
AE monitoring		✓	✓	✓	✓	✓	✓

BZ Benzodiazepine, BWSQ Benzodiazepine Withdrawal Symptom Questionnaire, ISI Insomnia Severity Index, HADS Hospital Anxiety and Depression Scale, SDS Substance Dependence Scale, CTRS Credibility of Treatment Rating Scale, AE adverse events

^aPrimary outcome